Canada markets closed

Design Therapeutics, Inc. (DSGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.6500-0.0700 (-1.88%)
At close: 04:00PM EDT
3.7200 +0.07 (+1.92%)
After hours: 07:39PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
41,695
57,063
48,613
24,778
6,060
Selling General and Administrative
17,633
21,127
18,980
11,053
2,496
Total Operating Expenses
59,328
78,190
67,593
35,831
8,330
Operating Income or Loss
-59,328
-78,190
-67,593
-35,831
-8,330
Total Other Income/Expenses Net
2,295
11,328
4,285
298
50
Income Before Tax
-57,033
-66,862
-63,308
-35,533
-8,280
Income from Continuing Operations
-57,033
-66,862
-63,308
-35,533
-8,280
Net Income
-57,033
-66,862
-63,308
-35,533
-8,280
Net Income available to common shareholders
-57,033
-66,862
-63,308
-35,533
-8,280
Basic EPS
-1.29
-
-1.14
-0.77
-0.15
Diluted EPS
-1.29
-
-1.14
-0.77
-0.15
Basic Average Shares
55,928
-
55,708
45,936
53,817
Diluted Average Shares
55,928
-
55,708
45,936
53,817